 | • レポートコード：QY20ST-05208 • 出版社/出版日：QYResearch / 2020年9月15日 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、132ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品、医療 |
| Single User | ￥560,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥840,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,120,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、世界の駆虫薬市場について種類別（経口薬、注射剤）、用途別（人間用、動物用）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・駆虫薬市場の概要 ・世界の主要地域別駆虫薬市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界の駆虫薬市場規模2015-2026：種類別（経口薬、注射剤） ・世界の駆虫薬市場規模2015-2026：用途別（人間用、動物用） ・駆虫薬の北米市場規模2015-2020 ・駆虫薬のヨーロッパ市場規模2015-2020 ・駆虫薬の中国市場規模2015-2020 ・駆虫薬の日本市場規模2015-2020 ・駆虫薬の東南アジア市場規模2015-2020 ・駆虫薬のインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 ・駆虫薬の製造コスト分析 ・販売チャネル、流通業者、顧客 ・駆虫薬の市場動向・機会・課題 ・調査の結論 |
A recently published report by QY Research titled Global Anthelmintic Drugs Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate data in a statistical manner. It examines the historic accomplishments and recent opportunities present in the global Anthelmintic Drugs market. QY Research report focuses on the consumption, geography, by type, by application, and the competitive landscape. The 4000 version of the report mainly splits the data for each region to analyze the leading companies, applications, and product types.
QY Research aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Report Overview:
Anthelmintics are drugs that work on helminths as either vermicides (by killing) or vermifuges (by expelling).
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Anthelmintic Drugs market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Anthelmintic Drugs industry.
Based on our recent survey, we have several different scenarios about the Anthelmintic Drugs YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Anthelmintic Drugs will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
QY Research report provides an overview and scope of the global Anthelmintic Drugs market, stating its drivers, trends, opportunities, and restraints. The report also comprises all key details of the global Anthelmintic Drugs market such as market strategies, sales volumes, and consumption. The report also covers the names of all distribution channels such as manufacturers, suppliers, wholesalers, distributors, consumers, and dealers.
QY Research also presents the statistical data in the form of infographics, tables, and charts to predict the trends and developments of the global Anthelmintic Drugs market over the forecast period. The research analysts have also used a framework such as key industry experts interview, research papers, refer journals, survey reports, and face-to-face interviews with expert professionals to know the detailed outlook of the global Anthelmintic Drugs market. The report also includes nautical information, where it shows Anthelmintic Drugs market product volume, utilization value, and production processes.
The research report also consists of a competitive landscape that describes the top players that are functioning in the global Anthelmintic Drugs market. This report also describes the key developments and trends, mergers and acquisitions strategies, and new product innovation that will show an enormous benefit to the companies that are competing in the global Anthelmintic Drugs market.
Geographical Analysis:
Based on region, the global Anthelmintic Drugs market is segmented into North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America). Research analysts have studied government initiatives, changing the political environment, and social scenarios that are likely to contribute to the growth of the regional markets.
Key Players:
The major players that are operating in the global Anthelmintic Drugs market are
Novartis
Pfizer
Bayer
Cipla
Sun Pharmaceutical Industries
Mankind Pharma
Johnson & Johnson
Merck
Segment by Type
Oral Drugs
Injectables
Segment by Application
For Human
For Animal
Competitive Landscape:
Factors such as cost analysis, marketing strategy, factor analysis, distributors, sourcing strategy, and industrial chain are all the parts of the global Anthelmintic Drugs market. The report also includes the analysis of the return on investment (ROI) feasibility with the estimated SWOT analysis.
The report covers the following objectives:
• Proliferation and maturation of trade in the global Anthelmintic Drugs market.
• The market share of the global Anthelmintic Drugs market, supply and demand ratio, growth revenue, supply chain analysis, and business overview.
• Current and future market trends that are influencing the growth opportunities and growth rate of the global Anthelmintic Drugs market.
• Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global Anthelmintic Drugs market.
1 Anthelmintic Drugs Market Overview
1.1 Anthelmintic Drugs Product Scope
1.2 Anthelmintic Drugs Segment by Type
1.2.1 Global Anthelmintic Drugs Sales by Type (2020-2026)
1.2.2 Oral Drugs
1.2.3 Injectables
1.3 Anthelmintic Drugs Segment by Application
1.3.1 Global Anthelmintic Drugs Sales Comparison by Application (2020-2026)
1.3.2 For Human
1.3.3 For Animal
1.4 Anthelmintic Drugs Market Estimates and Forecasts (2015-2026)
1.4.1 Global Anthelmintic Drugs Sales Growth Rate (2015-2026)
1.4.2 Global Anthelmintic Drugs Revenue and Growth Rate (2015-2026)
1.4.3 Global Anthelmintic Drugs Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): Anthelmintic Drugs Industry Impact
1.5.1 How the Covid-19 is Affecting the Anthelmintic Drugs Industry
1.5.1.1 Anthelmintic Drugs Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Anthelmintic Drugs Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Anthelmintic Drugs Players to Combat Covid-19 Impact
2 Anthelmintic Drugs Estimate and Forecast by Region
2.1 Global Anthelmintic Drugs Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Anthelmintic Drugs Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Anthelmintic Drugs Sales Market Share by Region (2015-2020)
2.2.2 Global Anthelmintic Drugs Revenue Market Share by Region (2015-2020)
2.3 Global Anthelmintic Drugs Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Anthelmintic Drugs Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Anthelmintic Drugs Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Anthelmintic Drugs Estimates and Projections (2015-2026)
2.4.2 Europe Anthelmintic Drugs Estimates and Projections (2015-2026)
2.4.3 China Anthelmintic Drugs Estimates and Projections (2015-2026)
2.4.4 Japan Anthelmintic Drugs Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Anthelmintic Drugs Estimates and Projections (2015-2026)
2.4.6 India Anthelmintic Drugs Estimates and Projections (2015-2026)
3 Global Anthelmintic Drugs Competition Landscape by Players
3.1 Global Top Anthelmintic Drugs Players by Sales (2015-2020)
3.2 Global Top Anthelmintic Drugs Players by Revenue (2015-2020)
3.3 Global Anthelmintic Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anthelmintic Drugs as of 2019)
3.4 Global Anthelmintic Drugs Average Price by Company (2015-2020)
3.5 Manufacturers Anthelmintic Drugs Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Anthelmintic Drugs Players (Opinion Leaders)
4 Global Anthelmintic Drugs Market Size by Type
4.1 Global Anthelmintic Drugs Historic Market Review by Type (2015-2020)
4.1.1 Global Anthelmintic Drugs Sales Market Share by Type (2015-2020)
4.1.2 Global Anthelmintic Drugs Revenue Market Share by Type (2015-2020)
4.1.3 Global Anthelmintic Drugs Price by Type (2014-2020)
4.2 Global Anthelmintic Drugs Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Anthelmintic Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Anthelmintic Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Global Anthelmintic Drugs Price Forecast by Type (2021-2026)
5 Global Anthelmintic Drugs Market Size by Application
5.1 Global Anthelmintic Drugs Historic Market Review by Application (2015-2020)
5.1.1 Global Anthelmintic Drugs Sales Market Share by Application (2015-2020)
5.1.2 Global Anthelmintic Drugs Revenue Market Share by Application (2015-2020)
5.1.3 Global Anthelmintic Drugs Price by Application (2015-2020)
5.2 Global Anthelmintic Drugs Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Anthelmintic Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Anthelmintic Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Anthelmintic Drugs Price Forecast by Application (2021-2026)
3 North America Anthelmintic Drugs Market Facts & Figures
3.2 North America Anthelmintic Drugs Sales Market Share by Company (2015-2020)
3.3 North America Anthelmintic Drugs Sales Market Share by Type (2015-2020)
3.4 North America Anthelmintic Drugs Sales Market Share by Application (2015-2020)
4 Europe Anthelmintic Drugs Market Facts & Figures
4.2 Europe Anthelmintic Drugs Sales Market Share by Company (2015-2020)
4.3 Europe Anthelmintic Drugs Sales Market Share by Type (2015-2020)
4.4 Europe Anthelmintic Drugs Sales Market Share by Application (2015-2020)
5 China Anthelmintic Drugs Market Facts & Figures
5.2 China Anthelmintic Drugs Sales Market Share by Company (2015-2020)
5.3 China Anthelmintic Drugs Sales Market Share by Type (2015-2020)
5.4 China Anthelmintic Drugs Sales Market Share by Application (2015-2020)
6 Japan Anthelmintic Drugs Market Facts & Figures
6.2 Japan Anthelmintic Drugs Sales Market Share by Company (2015-2020)
6.3 Japan Anthelmintic Drugs Sales Market Share by Type (2015-2020)
6.4 Japan Anthelmintic Drugs Sales Market Share by Application (2015-2020)
7 Southeast Asia Anthelmintic Drugs Market Facts & Figures
7.2 Southeast Asia Anthelmintic Drugs Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Anthelmintic Drugs Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Anthelmintic Drugs Sales Market Share by Application (2015-2020)
8 India Anthelmintic Drugs Market Facts & Figures
8.2 India Anthelmintic Drugs Sales Market Share by Company (2015-2020)
8.3 India Anthelmintic Drugs Sales Market Share by Type (2015-2020)
8.4 India Anthelmintic Drugs Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Anthelmintic Drugs Business
12.1 Novartis
12.1.1 Novartis Anthelmintic Drugs Corporation Information
12.1.2 Novartis Anthelmintic Drugs Business Overview and Total Revenue
12.1.3 Novartis Anthelmintic Drugs Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Novartis Anthelmintic Drugs Products Offered
12.1.5 Novartis Recent Development
12.2 Pfizer
12.2.1 Pfizer Anthelmintic Drugs Corporation Information
12.2.2 Pfizer Anthelmintic Drugs Business Overview and Total Revenue
12.2.3 Pfizer Anthelmintic Drugs Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Pfizer Anthelmintic Drugs Products Offered
12.2.5 Pfizer Recent Development
12.3 Bayer
12.3.1 Bayer Anthelmintic Drugs Corporation Information
12.3.2 Bayer Anthelmintic Drugs Business Overview and Total Revenue
12.3.3 Bayer Anthelmintic Drugs Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Bayer Anthelmintic Drugs Products Offered
12.3.5 Bayer Recent Development
12.4 Cipla
12.4.1 Cipla Anthelmintic Drugs Corporation Information
12.4.2 Cipla Anthelmintic Drugs Business Overview and Total Revenue
12.4.3 Cipla Anthelmintic Drugs Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Cipla Anthelmintic Drugs Products Offered
12.4.5 Cipla Recent Development
12.5 Sun Pharmaceutical Industries
12.5.1 Sun Pharmaceutical Industries Anthelmintic Drugs Corporation Information
12.5.2 Sun Pharmaceutical Industries Anthelmintic Drugs Business Overview and Total Revenue
12.5.3 Sun Pharmaceutical Industries Anthelmintic Drugs Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Sun Pharmaceutical Industries Anthelmintic Drugs Products Offered
12.5.5 Sun Pharmaceutical Industries Recent Development
12.6 Mankind Pharma
12.6.1 Mankind Pharma Anthelmintic Drugs Corporation Information
12.6.2 Mankind Pharma Anthelmintic Drugs Business Overview and Total Revenue
12.6.3 Mankind Pharma Anthelmintic Drugs Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Mankind Pharma Anthelmintic Drugs Products Offered
12.6.5 Mankind Pharma Recent Development
12.7 Johnson & Johnson
12.7.1 Johnson & Johnson Anthelmintic Drugs Corporation Information
12.7.2 Johnson & Johnson Anthelmintic Drugs Business Overview and Total Revenue
12.7.3 Johnson & Johnson Anthelmintic Drugs Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Johnson & Johnson Anthelmintic Drugs Products Offered
12.7.5 Johnson & Johnson Recent Development
12.8 Merck
12.8.1 Merck Anthelmintic Drugs Corporation Information
12.8.2 Merck Anthelmintic Drugs Business Overview and Total Revenue
12.8.3 Merck Anthelmintic Drugs Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Merck Anthelmintic Drugs Products Offered
12.8.5 Merck Recent Development
13 Anthelmintic Drugs Manufacturing Cost Analysis
13.1 Anthelmintic Drugs Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Anthelmintic Drugs
13.4 Anthelmintic Drugs Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Anthelmintic Drugs Distributors List
14.3 Anthelmintic Drugs Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Anthelmintic Drugs Sales (K Units) Growth Rate by Type (2020-2026)
Table 2. Global Anthelmintic Drugs Sales (K Units) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four Anthelmintic Drugs Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for Anthelmintic Drugs Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for Anthelmintic Drugs Players to Combat Covid-19 Impact
Table 8. Global Market Anthelmintic Drugs Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global Anthelmintic Drugs Sales (K Units) by Region (2015-2020)
Table 10. Global Anthelmintic Drugs Sales Market Share by Region (2015-2020)
Table 11. Global Anthelmintic Drugs Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global Anthelmintic Drugs Revenue Share by Region (2015-2020)
Table 13. Global Anthelmintic Drugs Sales (K Units) Forecast by Region (2021-2026)
Table 14. Global Anthelmintic Drugs Sales Market Share Forecast by Region (2021-2026)
Table 15. Global Anthelmintic Drugs Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global Anthelmintic Drugs Revenue Share Forecast by Region (2021-2026)
Table 17. Global Anthelmintic Drugs (K Units) of Key Companies (2015-2020)
Table 18. Global Anthelmintic Drugs Sales Share by Company (2015-2020)
Table 19. Global Anthelmintic Drugs Revenue (US$ Million) by Company (2015-2020)
Table 20. Global Anthelmintic Drugs Revenue Share by Company (2015-2020)
Table 21. Global Anthelmintic Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anthelmintic Drugs as of 2019)
Table 22. Global Anthelmintic Drugs Average Price (USD/Unit) of Key Company (2015-2020)
Table 23. Manufacturers Anthelmintic Drugs Manufacturing Sites and Area Served
Table 24. Manufacturers Anthelmintic Drugs Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key Anthelmintic Drugs Players
Table 27. Global Anthelmintic Drugs Sales (K Units) by Type (2015-2020)
Table 28. Global Anthelmintic Drugs Sales Share by Type (2015-2020)
Table 29. Global Anthelmintic Drugs Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global Anthelmintic Drugs Price (K Units) by Type (2015-2020)
Table 31. Global Anthelmintic Drugs Sales Share by Type (2021-2026)
Table 32. Global Anthelmintic Drugs Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global Anthelmintic Drugs Revenue Share by Type (2021-2026)
Table 34. Global Anthelmintic Drugs Price (K Units) by Type (2021-2026)
Table 35. Global Anthelmintic Drugs Sales (K Units) by Application (2015-2020)
Table 36. Global Anthelmintic Drugs Sales Share by Application (2015-2020)
Table 37. Global Anthelmintic Drugs Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global Anthelmintic Drugs Price (K Units) by Application (2015-2020)
Table 39. Global Anthelmintic Drugs Sales (K Units) by Application (2021-2026)
Table 40. Global Anthelmintic Drugs Sales Share by Application (2021-2026)
Table 41. Global Anthelmintic Drugs Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global Anthelmintic Drugs Revenue Share by Application (2021-2026)
Table 43. Global Anthelmintic Drugs Price (K Units) by Application (2021-2026)
Table 44. United States Anthelmintic Drugs Sales (K Units) by Company (2015-2020)
Table 45. United States Anthelmintic Drugs Sales Market Share by Company (2015-2020)
Table 46. United States Anthelmintic Drugs Sales (K Units) by Type (2015-2020)
Table 47. United States Anthelmintic Drugs Sales Market Share by Type (2015-2020)
Table 48. United States Anthelmintic Drugs Sales (K Units) by Application (2015-2020)
Table 49. United States Anthelmintic Drugs Sales Market Share by Application (2015-2020)
Table 50. Europe Anthelmintic Drugs Sales (K Units) by Company (2015-2020)
Table 51. Europe Anthelmintic Drugs Sales Market Share by Company (2015-2020)
Table 52. Europe Anthelmintic Drugs Sales (K Units) by Type (2015-2020)
Table 53. Europe Anthelmintic Drugs Sales Market Share by Type (2015-2020)
Table 54. Europe Anthelmintic Drugs Sales (K Units) by Application (2015-2020)
Table 55. Europe Anthelmintic Drugs Sales Market Share by Type (2015-2020)
Table 56. China Anthelmintic Drugs Sales (K Units) by Company (2015-2020)
Table 57. China Anthelmintic Drugs Sales Market Share by Company (2015-2020)
Table 58. China Anthelmintic Drugs Sales (K Units) by Type (2015-2020)
Table 59. China Anthelmintic Drugs Sales Market Share by Type (2015-2020)
Table 60. China Anthelmintic Drugs Sales (K Units) by Application (2015-2020)
Table 61. China Anthelmintic Drugs Sales Market Share by Application (2015-2020)
Table 62. Japan Anthelmintic Drugs Sales (K Units) by Company (2015-2020)
Table 63. Japan Anthelmintic Drugs Sales Market Share by Company (2015-2020)
Table 64. Japan Anthelmintic Drugs Sales (K Units) by Type (2015-2020)
Table 65. Japan Anthelmintic Drugs Sales Market Share by Type (2015-2020)
Table 66. Japan Anthelmintic Drugs Sales (K Units) by Application (2015-2020)
Table 67. Japan Anthelmintic Drugs Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia Anthelmintic Drugs Sales (K Units) by Company (2015-2020)
Table 69. Southeast Asia Anthelmintic Drugs Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia Anthelmintic Drugs Sales (K Units) by Type (2015-2020)
Table 71. Southeast Asia Anthelmintic Drugs Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia Anthelmintic Drugs Sales (K Units) by Type (2015-2020)
Table 73. Southeast Asia Anthelmintic Drugs Sales Market Share by Application (2015-2020)
Table 74. India Anthelmintic Drugs Sales (K Units) by Company (2015-2020)
Table 75. India Anthelmintic Drugs Sales Market Share by Company (2015-2020)
Table 76. India Anthelmintic Drugs Sales (K Units) by Type (2015-2020)
Table 77. India Anthelmintic Drugs Sales Market Share by Type (2015-2020)
Table 78. India Anthelmintic Drugs Sales (K Units) by Application (2015-2020)
Table 79. India Anthelmintic Drugs Sales Market Share by Application (2015-2020)
Table 80. Novartis Corporation Information
Table 81. Novartis Description and Business Overview
Table 82. Novartis Anthelmintic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. Novartis Anthelmintic Drugs Product
Table 84. Novartis Recent Development
Table 85. Pfizer Corporation Information
Table 86. Pfizer Description and Business Overview
Table 87. Pfizer Anthelmintic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. Pfizer Anthelmintic Drugs Product
Table 89. Pfizer Recent Development
Table 90. Bayer Corporation Information
Table 91. Bayer Description and Business Overview
Table 92. Bayer Anthelmintic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. Bayer Anthelmintic Drugs Product
Table 94. Bayer Recent Development
Table 95. Cipla Corporation Information
Table 96. Cipla Description and Business Overview
Table 97. Cipla Anthelmintic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. Cipla Anthelmintic Drugs Product
Table 99. Cipla Recent Development
Table 100. Sun Pharmaceutical Industries Corporation Information
Table 101. Sun Pharmaceutical Industries Description and Business Overview
Table 102. Sun Pharmaceutical Industries Anthelmintic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. Sun Pharmaceutical Industries Anthelmintic Drugs Product
Table 104. Sun Pharmaceutical Industries Recent Development
Table 105. Mankind Pharma Corporation Information
Table 106. Mankind Pharma Description and Business Overview
Table 107. Mankind Pharma Anthelmintic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 108. Mankind Pharma Anthelmintic Drugs Product
Table 109. Mankind Pharma Recent Development
Table 110. Johnson & Johnson Corporation Information
Table 111. Johnson & Johnson Description and Business Overview
Table 112. Johnson & Johnson Anthelmintic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 113. Johnson & Johnson Anthelmintic Drugs Product
Table 114. Johnson & Johnson Recent Development
Table . Merck Corporation Information
Table . Merck Anthelmintic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table . Merck Description and Business Overview
Table . Merck Anthelmintic Drugs Product
Table . Merck Recent Development
Table 120. Production Base and Market Concentration Rate of Raw Material
Table 121. Key Suppliers of Raw Materials
Table 122. Anthelmintic Drugs Distributors List
Table 123. Anthelmintic Drugs Customers List
Table 124. Market Key Trends
Table 125. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 126. Key Challenges
Table 127. Research Programs/Design for This Report
Table 128. Key Data Information from Secondary Sources
Table 129. Key Data Information from Primary Sources
List of Figures
Figure 1. Anthelmintic Drugs Product Picture
Figure 2. Global Anthelmintic Drugs Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Anthelmintic Drugs Market Share by Application in 2020 & 2026
Figure 6. For Human Examples
Figure 7. For Animal Examples
Figure 8. Global Anthelmintic Drugs Sales (K Units) Growth Rate (2015-2026)
Figure 9. Global Anthelmintic Drugs Revenue (US$ Million) Growth Rate (2015-2026)
Figure 10. Global Anthelmintic Drugs Price Trends Growth Rate (2015-2026) (USD/Unit)
Figure 11. Global Anthelmintic Drugs Revenue Market Share by Region: 2015 VS 2020
Figure 12. Global Anthelmintic Drugs Revenue Market Share by Region: 2021 VS 2026
Figure 13. United States Anthelmintic Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 14. United States Anthelmintic Drugs Sales (K Units) Growth Rate (2015-2026)
Figure 15. Europe Anthelmintic Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 16. Europe Anthelmintic Drugs Sales (Million USD) Growth Rate (2015-2026)
Figure 17. China Anthelmintic Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. China Anthelmintic Drugs Sales (Million USD) and Growth Rate (2015-2026)
Figure 19. Japan Anthelmintic Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. Japan Anthelmintic Drugs Sales (Million USD) Growth Rate (2015-2026)
Figure 21. Southeast Asia Anthelmintic Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Anthelmintic Drugs Sales (Million USD) Growth Rate (2015-2026)
Figure 23. India Anthelmintic Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. India Anthelmintic Drugs Sales (Million USD) Growth Rate (2015-2026)
Figure 25. Global 5 Largest Anthelmintic Drugs Players Market Share by Revenue in Anthelmintic Drugs 2015 & 2019
Figure 26. Anthelmintic Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 27. Global Anthelmintic Drugs Revenue Share by Type (2015-2020)
Figure 28. Global Anthelmintic Drugs Revenue Growth Rate by Type in 2015 & 2019
Figure 29. Global Anthelmintic Drugs Revenue Share by Application (2015-2020)
Figure 30. Global Anthelmintic Drugs Revenue Growth Rate by Application in 2015 & 2019
Figure 31. United States Anthelmintic Drugs Sales Market Share by Type in 2019
Figure 32. United States Anthelmintic Drugs Sales Market Share by Type in 2019
Figure 33. Europe Anthelmintic Drugs Sales Market Share by Company in 2019
Figure 34. Europe Anthelmintic Drugs Sales Market Share by Type in 2019
Figure 35. Europe Anthelmintic Drugs Sales Market Share by Application in 2019
Figure 36. China Anthelmintic Drugs Sales Market Share by Company in 2019
Figure 37. China Anthelmintic Drugs Sales Market Share by Type in 2019
Figure 38. China Anthelmintic Drugs Sales Market Share by Application in 2019
Figure 39. Japan Anthelmintic Drugs Sales Market Share by Company in 2019
Figure 40. Japan Anthelmintic Drugs Sales Market Share by Type in 2019
Figure 41. Japan Anthelmintic Drugs Sales Market Share by Application in 2019
Figure 42. Southeast Asia Anthelmintic Drugs Sales Market Share by Company in 2019
Figure 43. Southeast Asia Anthelmintic Drugs Sales Market Share by Type in 2019
Figure 44. Southeast Asia Anthelmintic Drugs Sales Market Share by Application in 2019
Figure 45. India Anthelmintic Drugs Sales Market Share by Company in 2019
Figure 46. India Anthelmintic Drugs Sales Market Share by Type in 2019
Figure 47. India Anthelmintic Drugs Sales Market Share by Application in 2019
Figure 48. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 49. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Bayer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Cipla Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Sun Pharmaceutical Industries Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Mankind Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Key Raw Materials Price Trend
Figure 57. Manufacturing Cost Structure of Anthelmintic Drugs
Figure 58. Manufacturing Process Analysis of Anthelmintic Drugs
Figure 59. Anthelmintic Drugs Industrial Chain Analysis
Figure 60. Channels of Distribution
Figure 61. Distributors Profiles
Figure 62. Porter's Five Forces Analysis
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
駆虫薬の世界市場レポート2020 A recently published report by QY Research titled Global Anthelmintic Drugs Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate…- 動物用処方薬の世界市場レポート2020 A recently published report by QY Research titled Global Animal Prescription Drugs Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides a…
- 抗コリン性乗り物酔い薬の世界市場レポート2020 A recently published report by QY Research titled Global Anticholinergic Travel Sickness Drugs Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statisticall…
- 犬用処方薬の世界市場レポート2020 A recently published report by QY Research titled Global Dog Prescription Drugs Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accu…
- 変形性関節症薬の世界市場レポート2020 A recently published report by QY Research titled Global Osteoarthritis Drugs Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accura…